No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Eiger BioPharmaceuticals Issues Chapter 11 Financial Update
Eiger BioPharmaceuticals Announces Bankruptcy and Liquidation Plan
Why Is Small Cap Amylyx Pharmaceuticals Stock Trading Higher On Wednesday?
Amylyx Jumps on Acquisition of Eiger's GLP-1 Drug
Amylyx Pharmaceuticals Shares Are Trading Higher After the Company Announced That It Acquired Avexitide From Eiger BioPharmaceuticals.
Express News | Eiger BioPharmaceuticals Inc - Sale of Co's Avexitide Asset Closed on July 9